Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
ERGO.L Stock Summary
In the News
ERGO.L Financial details
Company Rating
Neutral
Market Cap
771.71M
Income
0
Revenue
0
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
1.4K
Optionable
No
Shortable
Yes
Earnings
25 Sep 2023
P/E
44.78
Forward P/E
-
PEG
-
P/S
5.31
P/B
7.92
P/C
-
P/FCF
59.67
Quick Ratio
0.49
Current Ratio
1.5
Debt / Equity
0.03
LT Debt / Equity
0.02
-
-
EPS (TTM)
0
EPS next Y
-
EPS next Q
-
EPS this Y
15.38%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
NAN%
Revenue last 5Y
21.83%
Revenue Q/Q
-
EPS Q/Q
-
-
-
-
-
SMA20
0.6%
SMA50
-
SMA100
-
Inst Own
-
Inst Trans
-
ROA
12%
ROE
20%
ROC
0.21%
Gross Margin
41%
Oper. Margin
13%
Profit Margin
10%
Payout
-
Shs Outstand
57.25M
Shs Float
35.19M
-
-
-
-
Target Price
-
52W Range
895.0-1380.0
52W High
-2.46%
52W Low
+50.39%
RSI
60.05
Rel Volume
-
Avg Volume
922.96K
Volume
Perf Week
0%
Perf Month
0.15%
Perf Quarter
-
Perf Half Y
0.15%
-
-
-
-
Beta
0.829674
-
-
Volatility
0.99%, 5.41%
Prev Close
0%
Price
1346
Change
0%
ERGO.L Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 1.21 | 1.4 | 1.71 | 2.34 | 2.83 | |
Net income per share | -0.2 | 0.11 | 0.19 | 0.25 | 0.29 | |
Operating cash flow per share | 0.02 | 0.24 | 0.36 | 0.37 | 0.29 | |
Free cash flow per share | -0.01 | 0.22 | 0.34 | 0.35 | 0.25 | |
Cash per share | 0.12 | 0.29 | 0.38 | 0.62 | 0.37 | |
Book value per share | 0.63 | 0.76 | 1.05 | 1.33 | 1.65 | |
Tangible book value per share | 0.24 | 0.43 | 0.37 | 0.71 | 0.54 | |
Share holders equity per share | 0.63 | 0.76 | 1.05 | 1.33 | 1.65 | |
Interest debt per share | 0.01 | 0.12 | 0.11 | 0.06 | 0.07 | |
Market cap | 70.42M | 191.1M | 532.77M | 758.54M | 652.42M | |
Enterprise value | 65.24M | 182.28M | 518.89M | 729.98M | 636.23M | |
P/E ratio | -7.84 | 34.32 | 55.03 | 59.85 | 43.55 | |
Price to sales ratio | 1.3 | 2.8 | 6.17 | 6.4 | 4.49 | |
POCF ratio | 67.45 | 16.21 | 29.52 | 40.6 | 43.94 | |
PFCF ratio | -129.68 | 17.71 | 31.2 | 42.86 | 50.45 | |
P/B Ratio | 2.48 | 5.19 | 10.08 | 11.28 | 7.7 | |
PTB ratio | 2.48 | 5.19 | 10.08 | 11.28 | 7.7 | |
EV to sales | 1.21 | 2.67 | 6.01 | 6.16 | 4.38 | |
Enterprise value over EBITDA | -105.39 | 15.64 | 26.58 | 29.53 | 24.4 | |
EV to operating cash flow | 62.49 | 15.46 | 28.75 | 39.07 | 42.85 | |
EV to free cash flow | -120.14 | 16.89 | 30.39 | 41.24 | 49.19 | |
Earnings yield | -0.13 | 0.03 | 0.02 | 0.02 | 0.02 | |
Free cash flow yield | -0.01 | 0.06 | 0.03 | 0.02 | 0.02 | |
Debt to equity | 0 | 0.15 | 0.1 | 0.04 | 0.03 | |
Debt to assets | 0 | 0.1 | 0.06 | 0.03 | 0.02 | |
Net debt to EBITDA | 8.37 | -0.76 | -0.71 | -1.16 | -0.62 | |
Current ratio | 1.48 | 1.93 | 1.39 | 1.71 | 1.5 | |
Interest coverage | -1.66 | 29.08 | 33.58 | 54.5 | 30.79 | |
Income quality | -0.1 | 2.36 | 1.43 | 1.31 | 0.99 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.31 | 0.29 | 0 | 0 | 0 | |
Research and developement to revenue | 0.03 | 0.01 | 0 | 0 | 0 | |
Intangibles to total assets | 0.37 | 0.28 | 0.37 | 0.3 | 0.44 | |
Capex to operating cash flow | -1.52 | -0.08 | -0.05 | -0.05 | -0.13 | |
Capex to revenue | -0.03 | -0.01 | -0.01 | -0.01 | -0.01 | |
Capex to depreciation | -0.63 | -0.27 | -0.2 | -0.19 | -0.33 | |
Stock based compensation to revenue | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
Graham number | 1.69 | 1.4 | 2.13 | 2.74 | 3.3 | |
ROIC | -0.03 | 0.19 | 0.16 | 0.24 | 0.17 | |
Return on tangible assets | -0.3 | 0.14 | 0.17 | 0.17 | 0.21 | |
Graham Net | -0.3 | -0.12 | -0.41 | -0.15 | -0.5 | |
Working capital | 8.29M | 15.4M | 13.16M | 24.96M | 19.35M | |
Tangible asset value | 10.96M | 20.69M | 18.64M | 35.68M | 27.5M | |
Net current asset value | 6.97M | 11.79M | 7.29M | 21.59M | 13.64M | |
Invested capital | 0 | 0.15 | 0.1 | 0.04 | 0.03 | |
Average receivables | 0 | 0 | 0 | 0 | 0 | |
Average payables | 10.85M | 10.68M | 7.29M | 3.65M | 4.8M | |
Average inventory | 251K | 0 | 0 | 0 | 0 | |
Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
Days payables outstanding | 115.07 | 97.76 | 32.77 | 16.12 | 27.58 | |
Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
Payables turnover | 3.17 | 3.73 | 11.14 | 22.64 | 13.23 | |
Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
ROE | -0.32 | 0.15 | 0.18 | 0.19 | 0.18 | |
Capex per share | -0.04 | -0.02 | -0.02 | -0.02 | -0.04 |
Quarterly Fundamentals Overview
Last date of statement is 2023-06-30 for Q2
Metric | History | 2021-06-30 | 2021-12-31 | 2022-06-30 | 2022-12-31 | 2023-06-30 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0 | 0 | 0 | 0 | 0 | |
Net income per share | 0 | 0 | 0 | 0 | 0 | |
Operating cash flow per share | 0 | 0 | 0 | 0 | 0 | |
Free cash flow per share | 0 | 0 | 0 | 0 | 0 | |
Cash per share | 0 | 0 | 0 | 0 | 0 | |
Book value per share | 0 | 0 | 0 | 0 | 0 | |
Tangible book value per share | 0 | 0 | 0 | 0 | 0 | |
Share holders equity per share | 0 | 0 | 0 | 0 | 0 | |
Interest debt per share | 0 | 0 | 0 | 0 | 0 | |
Market cap | 0 | 0 | 0 | 0 | 0 | |
Enterprise value | -20.8M | -28.56M | -9.39M | -16.19M | -23.01M | |
P/E ratio | 0 | 0 | 0 | 0 | 0 | |
Price to sales ratio | 0 | 0 | 0 | 0 | 0 | |
POCF ratio | 0 | 0 | 0 | 0 | 0 | |
PFCF ratio | 0 | 0 | 0 | 0 | 0 | |
P/B Ratio | 0 | 0 | 0 | 0 | 0 | |
PTB ratio | 0 | 0 | 0 | 0 | 0 | |
EV to sales | 0 | 0 | 0 | 0 | 0 | |
Enterprise value over EBITDA | 0 | 0 | 0 | 0 | 0 | |
EV to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
EV to free cash flow | 0 | 0 | 0 | 0 | 0 | |
Earnings yield | 0 | 0 | 0 | 0 | 0 | |
Free cash flow yield | 0 | 0 | 0 | 0 | 0 | |
Debt to equity | 0.06 | 0.04 | 0.03 | 0.03 | 0.03 | |
Debt to assets | 0.04 | 0.03 | 0.02 | 0.02 | 0.02 | |
Net debt to EBITDA | 0 | 0 | 0 | 0 | 0 | |
Current ratio | 1.6 | 1.71 | 1.26 | 1.5 | 1.79 | |
Interest coverage | 0 | 0 | 0 | 0 | 0 | |
Income quality | 0 | 0 | 0 | 0 | 0 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.35 | 0.3 | 0.48 | 0.44 | 0.42 | |
Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 0 | 0 | 0 | 0 | 0 | |
ROIC | 0 | 0 | 0 | 0 | 0 | |
Return on tangible assets | 0 | 0 | 0 | 0 | 0 | |
Graham Net | 0 | 0 | 0 | 0 | 0 | |
Working capital | 19.12M | 24.96M | 10.81M | 19.35M | 29.61M | |
Tangible asset value | 25.6M | 35.68M | 17.07M | 27.5M | 35.09M | |
Net current asset value | 14.57M | 21.59M | 5.46M | 13.64M | 24.41M | |
Invested capital | 0.06 | 0.04 | 0.03 | 0.03 | 0.03 | |
Average receivables | 0 | 0 | 0 | 0 | 0 | |
Average payables | 0 | 0 | 0 | 0 | 0 | |
Average inventory | 0 | 0 | 0 | 0 | 0 | |
Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
Days payables outstanding | 0 | 0 | 0 | 0 | 0 | |
Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
Payables turnover | 0 | 0 | 0 | 0 | 0 | |
Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
ROE | 0 | 0 | 0 | 0 | 0 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
ERGO.L Frequently Asked Questions
What is Ergomed plc stock symbol ?
Ergomed plc is a GB stock and trading under the symbol ERGO.L
What is Ergomed plc stock quote today ?
Ergomed plc stock price is $1346 today.
Is Ergomed plc stock public?
Yes, Ergomed plc is a publicly traded company.